Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer
Phase 1 Completed
19 enrolled
TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery
Phase 1 Completed
7 enrolled
NORMAL-R
Phase 2 Completed
20 enrolled 11 charts
A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma
Phase 1 Completed
15 enrolled
Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
Phase 2 Completed
57 enrolled 10 charts
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
Phase 2 Completed
90 enrolled 10 charts
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
Phase 2 Completed
135 enrolled 17 charts
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
Phase 2 Completed
39 enrolled 13 charts
Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer
Phase 1 Completed
18 enrolled
A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
Phase 1 Completed
31 enrolled
A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum
Phase 3 Completed
326 enrolled
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer
Phase 1 Completed
20 enrolled